Clinical Trial Update: Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing nafamostat to unfractionated heparin in renal replacement therapy for sepsis-associated acute kidney injury; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Nafamostat (nafamostat mesylate)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Shen Lei | Conditions: Sepsis | Phase 4 | Status: NOT_YET_RECRUITING